Sarah Romano - Net Worth and Insider Trading
Sarah Romano Net Worth
The estimated net worth of Sarah Romano is at least $11,513 dollars as of 2024-12-27. Sarah Romano is the CFO of Entero Therapeutics Inc and owns about 18,014 shares of Entero Therapeutics Inc (ENTO) stock worth over $11,349. Sarah Romano is also the CFO of Kiora Pharmaceuticals Inc and owns about 49 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $164. Details can be seen in Sarah Romano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sarah Romano has not made any transactions after 2024-10-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sarah Romano
Sarah Romano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarah Romano owns 2 companies in total, including Kiora Pharmaceuticals Inc (KPRX) , and Entero Therapeutics Inc (ENTO) .
Click here to see the complete history of Sarah Romano’s form 4 insider trades.
Insider Ownership Summary of Sarah Romano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2019-11-05 | Chief Financial Officer |
| ENTO | Entero Therapeutics Inc | 2024-10-09 | Chief Financial Officer |
Sarah Romano Latest Holdings Summary
Sarah Romano currently owns a total of 2 stocks. Among these stocks, Sarah Romano owns 18,014 shares of Entero Therapeutics Inc (ENTO) as of October 9, 2024, with a value of $11,349 and a weighting of 98.57%. Sarah Romano also owns 49 shares of Kiora Pharmaceuticals Inc (KPRX) as of July 15, 2019, with a value of $164 and a weighting of 1.43%.
Latest Holdings of Sarah Romano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2024-10-09 | 18,014 | 0.63 | 11,349 |
| KPRX | Kiora Pharmaceuticals Inc | 2019-07-15 | 49 | 3.35 | 164 |
Holding Weightings of Sarah Romano
Sarah Romano Form 4 Trading Tracker
According to the SEC Form 4 filings, Sarah Romano has made a total of 7 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Entero Therapeutics Inc is the sale of 476 shares on October 9, 2024, which brought Sarah Romano around $214.
According to the SEC Form 4 filings, Sarah Romano has made a total of 0 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 4 shares on July 15, 2019, which brought Sarah Romano around $4,740.
Insider Trading History of Sarah Romano
- 1
Sarah Romano Trading Performance
GuruFocus tracks the stock performance after each of Sarah Romano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sarah Romano is 15.34%. GuruFocus also compares Sarah Romano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sarah Romano within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sarah Romano's insider trading performs compared to the benchmark.
Performance of Sarah Romano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.1 | | | | | |
| Relative Return to S&P 500(%) | 27.65 | | | | | |
Sarah Romano Ownership Network
Sarah Romano Owned Company Details
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Sarah Romano is the Chief Financial Officer of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
Over the past 18 months, Sarah Romano made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
Sarah Romano Mailing Address
Above is the net worth, insider trading, and ownership report for Sarah Romano. You might contact Sarah Romano via mailing address: 271 Waverly Oaks Road, Waltham Ma 02452.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
